Effects of Lifestyle Intervention in the Biological Aging in Prediabetes
Launched by KING SAUD UNIVERSITY · May 31, 2024
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how lifestyle changes, like eating healthier and exercising more, can affect the aging process in older adults in Saudi Arabia who have prediabetes. Prediabetes is a condition where blood sugar levels are higher than normal but not high enough to be classified as diabetes. The researchers want to see if making these lifestyle changes for six months can improve certain biological markers that indicate aging and health, potentially helping to reduce complications from prediabetes.
To be eligible for this study, participants need to be Saudi adults aged 30 and older who have been diagnosed with prediabetes and are able to follow a diet and exercise plan. Unfortunately, those who have insulin-dependent diabetes or other serious health issues that prevent them from exercising won’t be able to join. If someone participates, they can expect to engage in a guided program focused on diet and physical activity, with the hope of improving their overall health and well-being. This research could lead to practical benefits not only for individuals but also for public health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Clinical diagnosis of pre-diabetes for all Saudis aged 30 years and above, males and females
- • 2. They must be able to exercise and be able to follow a diet
- • Exclusion Criteria
- • 1. Insulin-dependent diabetes and non-diabetic patients
- • 2. People with diseases that prevent them from participating and doing exercises
About King Saud University
King Saud University (KSU), established in 1957, is a leading higher education institution in Saudi Arabia, renowned for its commitment to advancing research and innovation in various fields, including health sciences. With a robust infrastructure and a diverse pool of expert faculty, KSU actively engages in clinical trials aimed at improving healthcare outcomes and addressing pressing medical challenges. The university prioritizes ethical research practices and collaboration with local and international partners to contribute to the global body of medical knowledge, ultimately enhancing patient care and public health in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Shaun B Sabico, M.D.PhD
Study Chair
King Saud University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported